Quantcast

Latest Monoclonal antibodies Stories

2014-12-19 08:24:17

Developing Next Generation Cancer Immunotherapy with "Off-the-Shelf" Chimeric Antigen Receptor-Tumor Attacking Natural Killer (CAR-TNK(TM)) Cell Lines SAN DIEGO and CARDIFF-BY-THE-SEA,

2014-12-18 08:27:45

MONROVIA, Calif., Dec. 18, 2014 /PRNewswire/ -- Xencor, Inc.

2014-12-16 04:21:31

CAMBRIDGE, England, December 16, 2014 /PRNewswire/ -- Crescendo Biologics Limited (Crescendo) today announces a further equity investment from Astellas Venture Management

2014-12-13 12:20:50

ReportsandReports.com adds latest reports on Adalimumab Industry for Global and China Markets to its store. DALLAS, Dec.

2014-12-11 16:24:58

First Presentation of Phase 3 Data From Brodalumab Psoriasis Program THOUSAND OAKS, Calif. and LONDON, Dec.

2014-12-09 23:03:35

Symphogen has licensed the rights to the Selexis SUREtechnology Platform™ and SURE CHO-M Cell Line™ for the development of recombinant monoclonal antibody (MAb) mixtures for the treatment


Word of the Day
ultimo
  • In the month which preceded the present; in the last month, as distinguished from the current or present month and all others.
  • In the month which preceded the present; in the last month, as distinguished from the current or present month and all others.
The word 'ultimo' comes from the Latin phrase 'ultimo mense', 'in the last month'.
Related